25 XP   0   0   10

Prothena Corporation plc
Buy, Hold or Sell?

Let's analyse Prothena together

PenkeI guess you are interested in Prothena Corporation plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Prothena Corporation plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Prothena Corporation plc

I send you an email if I find something interesting about Prothena Corporation plc.

Quick analysis of Prothena (30 sec.)










What can you expect buying and holding a share of Prothena? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€9.84
Expected worth in 1 year
€8.78
How sure are you?
27.6%

+ What do you gain per year?

Total Gains per Share
€-1.06
Return On Investment
-5.4%

For what price can you sell your share?

Current Price per Share
€19.60
Expected price per share
€0 - €24.20
How sure are you?
50%

1. Valuation of Prothena (5 min.)




Live pricePrice per Share (EOD)

€19.60

Intrinsic Value Per Share

€-34.06 - €-40.65

Total Value Per Share

€-24.22 - €-30.81

2. Growth of Prothena (5 min.)




Is Prothena growing?

Current yearPrevious yearGrowGrow %
How rich?$561.3m$468.2m$123.6m20.9%

How much money is Prothena making?

Current yearPrevious yearGrowGrow %
Making money-$36.7m-$29.2m-$7.5m-20.5%
Net Profit Margin-6,211.6%-2,323.8%--

How much money comes from the company's main activities?

3. Financial Health of Prothena (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#94 / 1019

Most Revenue
#221 / 1019

Most Profit
#841 / 1019

Most Efficient
#926 / 1019

What can you expect buying and holding a share of Prothena? (5 min.)

Welcome investor! Prothena's management wants to use your money to grow the business. In return you get a share of Prothena.

What can you expect buying and holding a share of Prothena?

First you should know what it really means to hold a share of Prothena. And how you can make/lose money.

Speculation

The Price per Share of Prothena is €19.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Prothena.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Prothena, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €9.84. Based on the TTM, the Book Value Change Per Share is €-0.27 per quarter. Based on the YOY, the Book Value Change Per Share is €0.68 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Prothena.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-1.26-6.4%-0.72-3.7%-0.54-2.8%-0.37-1.9%-0.48-2.5%
Usd Book Value Change Per Share-1.04-5.3%-0.28-1.4%0.733.7%0.221.1%0.361.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.04-5.3%-0.28-1.4%0.733.7%0.221.1%0.361.8%
Usd Price Per Share36.75-49.53-46.86-31.91-32.79-
Price to Earnings Ratio-7.31--1.35-20.69-1.64--3.02-
Price-to-Total Gains Ratio-35.34--68.13--364.27--101.31--60.95-
Price to Book Ratio3.52-4.49-5.45-4.10-4.20-
Price-to-Total Gains Ratio-35.34--68.13--364.27--101.31--60.95-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share20.81716
Number of shares48
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.280.22
Usd Total Gains Per Share-0.280.22
Gains per Quarter (48 shares)-13.5510.65
Gains per Year (48 shares)-54.2142.60
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-54-6404333
20-108-11808576
30-163-1720128119
40-217-2260170162
50-271-2800213205
60-325-3340256248
70-379-3880298291
80-434-4420341334
90-488-4960383377
100-542-5500426420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%4.08.00.033.3%4.016.00.020.0%4.025.00.013.8%4.025.00.013.8%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%5.015.00.025.0%8.021.00.027.6%8.021.00.027.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.029.00.0%
Total Gains per Share1.03.00.025.0%5.07.00.041.7%5.015.00.025.0%8.021.00.027.6%8.021.00.027.6%

Fundamentals of Prothena

About Prothena Corporation plc

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States. The company is involved in developing birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, for the treatment of Parkinson's disease and other related synucleinopathies which is in Phase IIb clinical trial; NNC6019 that is in Phase lI clinical trial for the treatment of ATTR amyloidosis; and BMS-986446 and PRX012, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its discovery and preclinical programs include PRX123, a dual Aß-Tau vaccine for the treatment and prevention of Alzheimer's disease; and PRX019 for the treatment of neurogenerative diseases, as well as TDP-43 for the treatment of amyotrophic lateral sclerosis. Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target a-synuclein, including prasinezumab; and a collaboration agreement with Bristol-Myers Squibb to develop and commercialize antibodies targeting tau, TDP-43. The company was incorporated in 2012 and is based in Dublin, Ireland.

Fundamental data was last updated by Penke on 2024-04-05 07:04:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Prothena Corporation plc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Prothena earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Prothena to the Biotechnology industry mean.
  • A Net Profit Margin of -21,353.2% means that €-213.53 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Prothena Corporation plc:

  • The MRQ is -21,353.2%. The company is making a huge loss. -2
  • The TTM is -6,211.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-21,353.2%TTM-6,211.6%-15,141.6%
TTM-6,211.6%YOY-2,323.8%-3,887.8%
TTM-6,211.6%5Y-7,830.0%+1,618.4%
5Y-7,830.0%10Y-10,615.5%+2,785.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21,353.2%-197.2%-21,156.0%
TTM-6,211.6%-210.4%-6,001.2%
YOY-2,323.8%-279.3%-2,044.5%
5Y-7,830.0%-436.8%-7,393.2%
10Y-10,615.5%-599.3%-10,016.2%
1.1.2. Return on Assets

Shows how efficient Prothena is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Prothena to the Biotechnology industry mean.
  • -9.7% Return on Assets means that Prothena generated €-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Prothena Corporation plc:

  • The MRQ is -9.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.7%TTM-5.2%-4.5%
TTM-5.2%YOY-5.3%+0.1%
TTM-5.2%5Y-4.1%-1.1%
5Y-4.1%10Y-5.1%+1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.7%-13.6%+3.9%
TTM-5.2%-12.9%+7.7%
YOY-5.3%-11.9%+6.6%
5Y-4.1%-14.2%+10.1%
10Y-5.1%-16.2%+11.1%
1.1.3. Return on Equity

Shows how efficient Prothena is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Prothena to the Biotechnology industry mean.
  • -12.0% Return on Equity means Prothena generated €-0.12 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Prothena Corporation plc:

  • The MRQ is -12.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.0%TTM-6.4%-5.6%
TTM-6.4%YOY-7.2%+0.8%
TTM-6.4%5Y-6.2%-0.2%
5Y-6.2%10Y-7.4%+1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.0%-17.0%+5.0%
TTM-6.4%-16.1%+9.7%
YOY-7.2%-15.4%+8.2%
5Y-6.2%-20.0%+13.8%
10Y-7.4%-21.1%+13.7%

1.2. Operating Efficiency of Prothena Corporation plc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Prothena is operating .

  • Measures how much profit Prothena makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Prothena to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Prothena Corporation plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-413.7%+413.7%
TTM-413.7%YOY-2,475.6%+2,061.9%
TTM-413.7%5Y-6,391.8%+5,978.1%
5Y-6,391.8%10Y-9,503.6%+3,111.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM-413.7%-224.4%-189.3%
YOY-2,475.6%-288.4%-2,187.2%
5Y-6,391.8%-475.2%-5,916.6%
10Y-9,503.6%-624.7%-8,878.9%
1.2.2. Operating Ratio

Measures how efficient Prothena is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 249.47 means that the operating costs are €249.47 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Prothena Corporation plc:

  • The MRQ is 249.465. The company is inefficient in keeping operating costs low. -1
  • The TTM is 73.715. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ249.465TTM73.715+175.750
TTM73.715YOY25.756+47.959
TTM73.7155Y95.472-21.757
5Y95.47210Y128.508-33.036
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ249.4652.997+246.468
TTM73.7153.247+70.468
YOY25.7563.766+21.990
5Y95.4725.675+89.797
10Y128.5087.857+120.651

1.3. Liquidity of Prothena Corporation plc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Prothena is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 11.24 means the company has €11.24 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Prothena Corporation plc:

  • The MRQ is 11.237. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.991. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.237TTM11.991-0.754
TTM11.991YOY13.232-1.241
TTM11.9915Y15.238-3.247
5Y15.23810Y15.169+0.069
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.2373.930+7.307
TTM11.9914.251+7.740
YOY13.2325.436+7.796
5Y15.2386.045+9.193
10Y15.1696.363+8.806
1.3.2. Quick Ratio

Measures if Prothena is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Prothena to the Biotechnology industry mean.
  • A Quick Ratio of 0.09 means the company can pay off €0.09 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Prothena Corporation plc:

  • The MRQ is 0.091. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.049. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.091TTM0.049+0.042
TTM0.049YOY0.016+0.032
TTM0.0495Y0.014+0.034
5Y0.01410Y0.134-0.120
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0913.629-3.538
TTM0.0494.065-4.016
YOY0.0165.397-5.381
5Y0.0145.993-5.979
10Y0.1346.277-6.143

1.4. Solvency of Prothena Corporation plc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Prothena assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Prothena to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.19 means that Prothena assets are financed with 19.4% credit (debt) and the remaining percentage (100% - 19.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Prothena Corporation plc:

  • The MRQ is 0.194. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.185. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.194TTM0.185+0.009
TTM0.185YOY0.238-0.053
TTM0.1855Y0.293-0.107
5Y0.29310Y0.280+0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1940.332-0.138
TTM0.1850.334-0.149
YOY0.2380.268-0.030
5Y0.2930.366-0.073
10Y0.2800.390-0.110
1.4.2. Debt to Equity Ratio

Measures if Prothena is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Prothena to the Biotechnology industry mean.
  • A Debt to Equity ratio of 24.1% means that company has €0.24 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Prothena Corporation plc:

  • The MRQ is 0.241. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.228. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.241TTM0.228+0.013
TTM0.228YOY0.316-0.088
TTM0.2285Y0.434-0.207
5Y0.43410Y0.410+0.025
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2410.381-0.140
TTM0.2280.390-0.162
YOY0.3160.334-0.018
5Y0.4340.434+0.000
10Y0.4100.466-0.056

2. Market Valuation of Prothena Corporation plc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Prothena generates.

  • Above 15 is considered overpriced but always compare Prothena to the Biotechnology industry mean.
  • A PE ratio of -7.31 means the investor is paying €-7.31 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Prothena Corporation plc:

  • The EOD is -4.143. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.315. Based on the earnings, the company is expensive. -2
  • The TTM is -1.352. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.143MRQ-7.315+3.171
MRQ-7.315TTM-1.352-5.963
TTM-1.352YOY20.686-22.038
TTM-1.3525Y1.639-2.990
5Y1.63910Y-3.022+4.660
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.143-2.315-1.828
MRQ-7.315-2.560-4.755
TTM-1.352-2.664+1.312
YOY20.686-4.122+24.808
5Y1.639-6.258+7.897
10Y-3.022-6.108+3.086
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Prothena Corporation plc:

  • The EOD is -5.317. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.386. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 7.406. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-5.317MRQ-9.386+4.069
MRQ-9.386TTM7.406-16.791
TTM7.406YOY-51.276+58.682
TTM7.4065Y-10.566+17.972
5Y-10.56610Y-7.287-3.279
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.317-3.067-2.250
MRQ-9.386-3.251-6.135
TTM7.406-3.545+10.951
YOY-51.276-5.595-45.681
5Y-10.566-8.315-2.251
10Y-7.287-8.708+1.421
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Prothena is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.52 means the investor is paying €3.52 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Prothena Corporation plc:

  • The EOD is 1.992. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.517. Based on the equity, the company is fair priced.
  • The TTM is 4.495. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.992MRQ3.517-1.525
MRQ3.517TTM4.495-0.978
TTM4.495YOY5.445-0.950
TTM4.4955Y4.098+0.397
5Y4.09810Y4.200-0.103
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9921.905+0.087
MRQ3.5172.111+1.406
TTM4.4952.095+2.400
YOY5.4452.836+2.609
5Y4.0983.443+0.655
10Y4.2003.794+0.406
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Prothena Corporation plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.979-0.266-73%0.684-243%0.209-569%0.339-389%
Book Value Per Share--9.83810.374-5%8.206+20%6.817+44%6.896+43%
Current Ratio--11.23711.991-6%13.232-15%15.238-26%15.169-26%
Debt To Asset Ratio--0.1940.185+5%0.238-19%0.293-34%0.280-31%
Debt To Equity Ratio--0.2410.228+6%0.316-24%0.434-45%0.410-41%
Dividend Per Share----0%-0%-0%-0%
Eps---1.183-0.678-43%-0.512-57%-0.345-71%-0.454-62%
Free Cash Flow Per Share---0.922-0.599-35%-0.479-48%-0.257-72%-0.257-72%
Free Cash Flow To Equity Per Share---0.913-0.401-56%0.579-258%0.355-357%0.355-357%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---40.647--------
Intrinsic Value_10Y_min---34.063--------
Intrinsic Value_1Y_max---1.361--------
Intrinsic Value_1Y_min---1.335--------
Intrinsic Value_3Y_max---6.156--------
Intrinsic Value_3Y_min---5.835--------
Intrinsic Value_5Y_max---13.443--------
Intrinsic Value_5Y_min---12.299--------
Market Cap1052921800.000-77%1858729300.0002505255517.500-26%2370014158.750-22%1613790680.250+15%1658666748.276+12%
Net Profit Margin---213.532-62.116-71%-23.238-89%-78.300-63%-106.155-50%
Operating Margin----4.1370%-24.7560%-63.9180%-95.0360%
Operating Ratio--249.46573.715+238%25.756+869%95.472+161%128.508+94%
Pb Ratio1.992-77%3.5174.495-22%5.445-35%4.098-14%4.200-16%
Pe Ratio-4.143+43%-7.315-1.352-82%20.686-135%1.639-546%-3.022-59%
Price Per Share19.600-77%34.60046.635-26%44.118-22%30.041+15%30.876+12%
Price To Free Cash Flow Ratio-5.317+43%-9.3867.406-227%-51.276+446%-10.566+13%-7.287-22%
Price To Total Gains Ratio-20.020+43%-35.341-68.133+93%-364.275+931%-101.306+187%-60.947+72%
Quick Ratio--0.0910.049+86%0.016+451%0.014+539%0.134-32%
Return On Assets---0.097-0.052-47%-0.053-45%-0.041-58%-0.051-47%
Return On Equity---0.120-0.064-47%-0.072-40%-0.062-49%-0.074-39%
Total Gains Per Share---0.979-0.266-73%0.684-243%0.209-569%0.339-389%
Usd Book Value--561346559.160591900555.428-5%468203619.006+20%388982021.521+44%393439661.289+43%
Usd Book Value Change Per Share---1.040-0.282-73%0.726-243%0.222-569%0.360-389%
Usd Book Value Per Share--10.44911.018-5%8.716+20%7.241+44%7.324+43%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.256-0.720-43%-0.544-57%-0.366-71%-0.482-62%
Usd Free Cash Flow---52585272.517-34177877.220-35%-27320352.497-48%-11726064.786-78%-8086941.232-85%
Usd Free Cash Flow Per Share---0.979-0.636-35%-0.509-48%-0.273-72%-0.273-72%
Usd Free Cash Flow To Equity Per Share---0.970-0.426-56%0.615-258%0.377-357%0.377-357%
Usd Market Cap1118308243.780-77%1974156389.5302660831885.137-26%2517192038.008-22%1714007081.494+15%1761669953.344+12%
Usd Price Per Share20.817-77%36.74949.531-26%46.857-22%31.906+15%32.793+12%
Usd Profit---67473783.413-36755792.533-46%-29236289.556-57%-19290516.286-71%-25640812.844-62%
Usd Revenue--315989.61922841749.624-99%13475807.305-98%17375379.200-98%12970746.311-98%
Usd Total Gains Per Share---1.040-0.282-73%0.726-243%0.222-569%0.360-389%
 EOD+3 -5MRQTTM+6 -26YOY+10 -225Y+12 -2010Y+12 -20

3.2. Fundamental Score

Let's check the fundamental score of Prothena Corporation plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.143
Price to Book Ratio (EOD)Between0-11.992
Net Profit Margin (MRQ)Greater than0-213.532
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.091
Current Ratio (MRQ)Greater than111.237
Debt to Asset Ratio (MRQ)Less than10.194
Debt to Equity Ratio (MRQ)Less than10.241
Return on Equity (MRQ)Greater than0.15-0.120
Return on Assets (MRQ)Greater than0.05-0.097
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Prothena Corporation plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose19.800
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets696,382
Total Liabilities135,017
Total Stockholder Equity561,365
 As reported
Total Liabilities 135,017
Total Stockholder Equity+ 561,365
Total Assets = 696,382

Assets

Total Assets696,382
Total Current Assets639,282
Long-term Assets57,100
Total Current Assets
Cash And Cash Equivalents 618,830
Net Receivables 5,159
Other Current Assets 2,140
Total Current Assets  (as reported)639,282
Total Current Assets  (calculated)626,129
+/- 13,153
Long-term Assets
Property Plant Equipment 15,998
Long-term Assets Other 7,209
Long-term Assets  (as reported)57,100
Long-term Assets  (calculated)23,207
+/- 33,893

Liabilities & Shareholders' Equity

Total Current Liabilities56,891
Long-term Liabilities78,126
Total Stockholder Equity561,365
Total Current Liabilities
Accounts payable 25,391
Other Current Liabilities 2,129
Total Current Liabilities  (as reported)56,891
Total Current Liabilities  (calculated)27,520
+/- 29,371
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt11,835
Long-term Liabilities  (as reported)78,126
Long-term Liabilities  (calculated)11,835
+/- 66,291
Total Stockholder Equity
Total Stockholder Equity (as reported)561,365
Total Stockholder Equity (calculated)0
+/- 561,365
Other
Capital Stock537
Common Stock Shares Outstanding 53,682
Net Invested Capital 561,365
Net Working Capital 582,391
Property Plant and Equipment Gross 23,413



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
459,976
581,950
579,000
537,680
496,329
606,647
563,300
524,626
498,796
459,534
462,072
450,894
419,268
399,421
378,933
355,784
332,975
379,719
436,378
632,704
609,366
581,412
549,589
554,440
758,035
741,586
720,649
746,920
696,382
696,382746,920720,649741,586758,035554,440549,589581,412609,366632,704436,378379,719332,975355,784378,933399,421419,268450,894462,072459,534498,796524,626563,300606,647496,329537,680579,000581,950459,976
   > Total Current Assets 
391,362
514,204
511,720
469,064
426,327
537,153
494,037
456,908
431,390
415,193
418,708
409,202
378,375
359,691
341,123
320,485
299,284
352,301
409,468
607,530
584,809
555,620
521,294
524,562
719,098
700,343
677,103
690,604
639,282
639,282690,604677,103700,343719,098524,562521,294555,620584,809607,530409,468352,301299,284320,485341,123359,691378,375409,202418,708415,193431,390456,908494,037537,153426,327469,064511,720514,204391,362
       Cash And Cash Equivalents 
386,923
506,550
471,729
456,061
417,620
429,039
486,212
451,512
427,659
410,106
398,144
390,304
375,723
352,685
333,942
314,525
295,380
342,993
399,831
600,098
579,094
542,994
508,795
495,628
710,406
686,184
659,111
670,897
618,830
618,830670,897659,111686,184710,406495,628508,795542,994579,094600,098399,831342,993295,380314,525333,942352,685375,723390,304398,144410,106427,659451,512486,212429,039417,620456,061471,729506,550386,923
       Net Receivables 
178
271
30,240
220
240
100,012
8
0
2
7
0
42
68
174
56
22
15
1
3
79
0
0
0
3,267
62
0
524
5,159
5,159
5,1595,1595240623,2670007931152256174684207208100,01224022030,240271178
       Other Current Assets 
4,261
7,383
9,751
12,783
8,707
8,102
0
0
3,729
1,352
17,102
18,856
0
0
0
1,352
1,352
1,352
1,352
0
5,715
12,626
12,499
17,214
1,708
3,270
1,352
3,051
2,140
2,1403,0511,3523,2701,70817,21412,49912,6265,71501,3521,3521,3521,35200018,85617,1021,3523,729008,1028,70712,7839,7517,3834,261
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
44,341
43,364
41,692
40,893
39,730
37,810
35,299
33,691
27,418
26,910
25,174
24,557
25,792
28,295
29,878
38,937
41,243
43,546
56,316
57,100
57,10056,31643,54641,24338,93729,87828,29525,79224,55725,17426,91027,41833,69135,29937,81039,73040,89341,69243,36444,341000000000
       Property Plant Equipment 
56,452
56,084
55,843
55,384
54,990
54,278
53,398
52,951
52,835
31,866
30,245
28,852
27,148
25,460
23,785
22,096
20,362
18,706
17,076
15,511
14,135
12,529
11,201
9,805
8,008
6,643
5,477
15,062
15,998
15,99815,0625,4776,6438,0089,80511,20112,52914,13515,51117,07618,70620,36222,09623,78525,46027,14828,85230,24531,86652,83552,95153,39854,27854,99055,38455,84356,08456,452
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
3,572
3,627
3,381
3,789
3,819
3,008
1,679
13,329
1,690
3,403
3,160
10,422
3,671
5,136
20,073
30,929
13,167
12,127
11,338
7,209
7,20911,33812,12713,16730,92920,0735,1363,67110,4223,1603,4031,69013,3291,6793,0083,8193,7893,3813,6273,572000000000
> Total Liabilities 
94,573
85,702
92,024
91,426
89,140
197,142
207,294
184,976
175,798
147,404
159,265
161,719
146,347
144,382
144,489
146,270
148,969
145,135
148,171
142,233
143,324
142,525
142,290
149,792
135,993
134,177
138,970
129,693
135,017
135,017129,693138,970134,177135,993149,792142,290142,525143,324142,233148,171145,135148,969146,270144,489144,382146,347161,719159,265147,404175,798184,976207,294197,14289,14091,42692,02485,70294,573
   > Total Current Liabilities 
41,075
33,680
39,599
39,258
37,371
35,555
46,132
23,627
14,926
14,906
28,016
31,763
17,714
17,086
18,544
21,722
25,848
23,456
52,899
29,201
33,452
36,496
40,107
50,598
50,147
48,884
71,565
53,370
56,891
56,89153,37071,56548,88450,14750,59840,10736,49633,45229,20152,89923,45625,84821,72218,54417,08617,71431,76328,01614,90614,92623,62746,13235,55537,37139,25839,59933,68041,075
       Short-term Debt 
51,320
51,735
52,148
52,274
52,248
52,202
52,165
0
0
4,810
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000004,8100052,16552,20252,24852,27452,14851,73551,320
       Short Long Term Debt 
51,320
51,735
52,148
52,274
52,248
52,202
52,165
0
0
4,810
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000004,8100052,16552,20252,24852,27452,14851,73551,320
       Accounts payable 
32,520
28,349
12,545
11,062
13,633
11,590
10,052
4,485
1,470
2,103
1,525
2,418
1,242
3,297
2,124
2,810
4,117
4,212
5,908
3,483
3,691
9,316
7,551
9,788
9,270
12,523
13,851
19,458
25,391
25,39119,45813,85112,5239,2709,7887,5519,3163,6913,4835,9084,2124,1172,8102,1243,2971,2422,4181,5252,1031,4704,48510,05211,59013,63311,06212,54528,34932,520
       Other Current Liabilities 
8,555
5,331
1,670
1,449
1,716
2,043
19,891
6,768
837
783
673
681
327
558
894
873
552
246
25,492
7,633
8,062
10,044
10,675
10,379
11,945
1,825
49,190
3,106
2,129
2,1293,10649,1901,82511,94510,37910,67510,0448,0627,63325,4922465528738945583276816737838376,76819,8912,0431,7161,4491,6705,3318,555
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
132,498
131,249
129,956
128,633
127,296
125,945
124,548
123,121
121,679
95,272
113,032
109,872
106,029
102,183
99,194
85,846
85,293
67,405
76,323
78,126
78,12676,32367,40585,29385,84699,194102,183106,029109,872113,03295,272121,679123,121124,548125,945127,296128,633129,956131,249132,498000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
26,513
25,358
24,163
22,939
21,703
20,454
19,161
17,838
16,501
15,149
13,753
12,326
10,884
9,577
8,034
6,473
4,885
3,448
10,735
11,835
11,83510,7353,4484,8856,4738,0349,57710,88412,32613,75315,14916,50117,83819,16120,45421,70322,93924,16325,35826,513000000000
       Other Liabilities 
98
287
277
266
254
110,485
110,471
111,011
110,971
110,795
110,795
110,795
110,795
110,795
110,795
110,795
110,795
110,795
85,846
105,110
103,486
101,195
98,905
97,545
85,846
0
67,405
0
0
0067,405085,84697,54598,905101,195103,486105,11085,846110,795110,795110,795110,795110,795110,795110,795110,795110,795110,971111,011110,471110,48525426627728798
> Total Stockholder Equity
365,403
496,248
486,976
446,254
407,189
409,505
356,006
339,650
322,998
312,130
302,807
289,175
272,921
255,039
234,444
209,514
184,006
234,584
288,207
490,471
466,042
438,887
407,299
404,648
622,042
607,409
581,679
617,227
561,365
561,365617,227581,679607,409622,042404,648407,299438,887466,042490,471288,207234,584184,006209,514234,444255,039272,921289,175302,807312,130322,998339,650356,006409,505407,189446,254486,976496,248365,403
   Common Stock
348
380
382
384
385
398
398
398
399
399
399
399
399
399
399
399
399
442
449
465
466
467
468
479
521
0
581,679
0
0
00581,6790521479468467466465449442399399399399399399399399399398398398385384382380348
   Retained Earnings Total Equity00000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000
   Capital Surplus 00000000000000000000000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 00000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue91,370
Cost of Revenue--
Gross Profit-91,370
 
Operating Income (+$)
Gross Profit-
Operating Expense-282,406
Operating Income-191,036-282,406
 
Operating Expense (+$)
Research Development220,571
Selling General Administrative61,835
Selling And Marketing Expenses-
Operating Expense282,406282,406
 
Net Interest Income (+$)
Interest Income31,014
Interest Expense--
Other Finance Cost-0
Net Interest Income31,014
 
Pretax Income (+$)
Operating Income-191,036
Net Interest Income31,014
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-160,480-190,578
EBIT - interestExpense = 0
-147,028
-147,028
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--160,480
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-160,480
Tax Provision--13,452
Net Income From Continuing Ops-147,028-147,028
Net Income-147,028
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-458-31,014
 

Technical Analysis of Prothena
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Prothena. The general trend of Prothena is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Prothena's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Prothena Corporation plc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 21.20 < 21.60 < 24.20.

The bearish price targets are: .

Tweet this
Prothena Corporation plc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Prothena Corporation plc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Prothena Corporation plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Prothena Corporation plc.

Prothena Corporation plc Daily Moving Average Convergence/Divergence (MACD) ChartProthena Corporation plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Prothena Corporation plc. The current adx is .

Prothena Corporation plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Prothena Corporation plc.

Prothena Corporation plc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Prothena Corporation plc.

Prothena Corporation plc Daily Relative Strength Index (RSI) ChartProthena Corporation plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Prothena Corporation plc.

Prothena Corporation plc Daily Stochastic Oscillator ChartProthena Corporation plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Prothena Corporation plc.

Prothena Corporation plc Daily Commodity Channel Index (CCI) ChartProthena Corporation plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Prothena Corporation plc.

Prothena Corporation plc Daily Chande Momentum Oscillator (CMO) ChartProthena Corporation plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Prothena Corporation plc.

Prothena Corporation plc Daily Williams %R ChartProthena Corporation plc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Prothena Corporation plc.

Prothena Corporation plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Prothena Corporation plc.

Prothena Corporation plc Daily Average True Range (ATR) ChartProthena Corporation plc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Prothena Corporation plc.

Prothena Corporation plc Daily On-Balance Volume (OBV) ChartProthena Corporation plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Prothena Corporation plc.

Prothena Corporation plc Daily Money Flow Index (MFI) ChartProthena Corporation plc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Prothena Corporation plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-02 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-11 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-07 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-12 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-03 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-15 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Prothena Corporation plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Prothena Corporation plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose19.800
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Prothena with someone you think should read this too:
  • Are you bullish or bearish on Prothena? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Prothena? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Prothena Corporation plc

I send you an email if I find something interesting about Prothena Corporation plc.


Comments

How you think about this?

Leave a comment

Stay informed about Prothena Corporation plc.

Receive notifications about Prothena Corporation plc in your mailbox!